Home › Funds › Manulife Financial › CLOV
Manulife Financial position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q2 2026)109.63K sh
Reported value held$574.45K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 145.38K | $311.00K | New |
| Q3 2022 | 142.79K | $243.00K | Reduce |
| Q4 2022 | 151.42K | $140.75K | Add |
| Q1 2023 | 151.42K | $127.97K | Hold |
| Q1 2025 | 77.77K | $279.21K | New |
| Q2 2025 | 212.16K | $591.92K | Add |
| Q3 2025 | 201.80K | $617.50K | Reduce |
| Q4 2025 | 191.50K | $450.02K | Reduce |
| Q1 2026 | 110.16K | $193.88K | Reduce |
| Q2 2026 | 109.63K | $574.45K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Marshall Wace 1.56M sh · $8.19M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026
- BNY Mellon 1.21M sh · $6.35M · Q2 2026